Senseonics Holdings, Inc. (SENS)
USD 0.6
(0.3%)
USD 0.6
(0.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 78.69 Million USD | 10.29% |
| 2022 | 71.35 Million USD | 26.58% |
| 2021 | 56.37 Million USD | -8.73% |
| 2020 | 61.76 Million USD | -44.46% |
| 2019 | 111.21 Million USD | 40.01% |
| 2018 | 79.43 Million USD | 50.08% |
| 2017 | 52.92 Million USD | 25.7% |
| 2016 | 42.1 Million USD | 45.94% |
| 2015 | 28.85 Million USD | 54.26% |
| 2014 | 18.7 Million USD | -0.53% |
| 2013 | 18.8 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 FY | 78.69 Million USD | 10.29% |
| 2023 Q1 | 20.19 Million USD | -0.45% |
| 2023 Q4 | 19.79 Million USD | 6.59% |
| 2023 Q3 | 18.56 Million USD | 2.62% |
| 2023 Q2 | 18.09 Million USD | -10.4% |
| 2022 Q2 | 19.48 Million USD | 6.3% |
| 2022 Q3 | 20.12 Million USD | 3.3% |
| 2022 Q4 | 20.28 Million USD | 0.81% |
| 2022 Q1 | 18.32 Million USD | 2.6% |
| 2022 FY | 71.35 Million USD | 26.58% |
| 2021 Q3 | 15.68 Million USD | 16.53% |
| 2021 Q2 | 13.46 Million USD | -8.95% |
| 2021 Q4 | 17.86 Million USD | 13.85% |
| 2021 Q1 | 14.78 Million USD | -9.19% |
| 2021 FY | 56.37 Million USD | -8.73% |
| 2020 Q1 | 13.3 Million USD | 16.87% |
| 2020 Q4 | 16.28 Million USD | 37.49% |
| 2020 FY | 61.76 Million USD | -44.46% |
| 2020 Q2 | 12.88 Million USD | -3.16% |
| 2020 Q3 | 11.84 Million USD | -8.07% |
| 2019 Q1 | 28.02 Million USD | -6.9% |
| 2019 FY | 111.21 Million USD | 40.01% |
| 2019 Q4 | 11.38 Million USD | -52.96% |
| 2019 Q3 | 24.19 Million USD | -9.14% |
| 2019 Q2 | 26.63 Million USD | -4.97% |
| 2018 Q2 | 23.62 Million USD | 15.87% |
| 2018 Q1 | 20.39 Million USD | 2.74% |
| 2018 Q3 | 26.45 Million USD | 11.98% |
| 2018 Q4 | 30.1 Million USD | 13.77% |
| 2018 FY | 79.43 Million USD | 50.08% |
| 2017 Q3 | 15.56 Million USD | 7.07% |
| 2017 FY | 52.92 Million USD | 25.7% |
| 2017 Q4 | 19.84 Million USD | 27.52% |
| 2017 Q2 | 14.53 Million USD | -7.67% |
| 2017 Q1 | 15.74 Million USD | 46.59% |
| 2016 Q2 | 9.2 Million USD | -11.78% |
| 2016 Q1 | 10.43 Million USD | -9.54% |
| 2016 Q3 | 11.9 Million USD | 29.32% |
| 2016 Q4 | 10.74 Million USD | -9.78% |
| 2016 FY | 42.1 Million USD | 45.94% |
| 2015 FY | 28.85 Million USD | 54.26% |
| 2015 Q1 | 1759.00 USD | -95.78% |
| 2015 Q2 | 8.15 Million USD | 463345.08% |
| 2015 Q3 | 10.92 Million USD | 34.05% |
| 2015 Q4 | 11.53 Million USD | 5.55% |
| 2014 FY | 18.7 Million USD | -0.53% |
| 2014 Q3 | 1659.00 USD | -36.94% |
| 2014 Q4 | 41.64 Thousand USD | 2410.37% |
| 2014 Q1 | 21.65 Thousand USD | 0.0% |
| 2014 Q2 | 2631.00 USD | -87.85% |
| 2013 FY | 18.8 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Perspective Therapeutics, Inc. | 17.42 Million USD | -351.59% |
| Electromed, Inc. | 35.14 Million USD | -123.912% |
| Catheter Precision, Inc. | 15.52 Million USD | -406.984% |
| Xtant Medical Holdings, Inc. | 65.62 Million USD | -19.915% |